Preeclampsia-eclampsia “manejo en uci reto para el gineco-obstetra”

BIBLOGRAFIA

1. Rosie Burton, PhD, MRCOG, Michael Belfort, MD & John Anthony, FCOG Management of the Pregnant ICU Patient. Clinical Pulmonary Medicine • Volume 9, Number 2 • March 2002
2. Myers JE, Baker PN. Hipertensive diseases and eclampsia. Curr Opin Obstet Gynecol 2002; 14: 119-125
3. Pridjian G, Puschett JB. Preeclampisa. Part 1: Clinical and Pathophysiologic Considerations. Obstet andGynecol Survey 2002; 57 (9): 598-618
4. Barrilleaux PS, Martin JN. Hypertensión Therapy During Pregnancy. Clin Obstet Gynecol 2002; 45 (1): 22-34
5. Wilson MI, Goodwin TM, Pan VI, Ingles SA. Molecular epidemiology of preeclampsia. Obstet and Gynecol Survey 2003; 58(1):39-6
6. Castro LJ. Mortalidad materna. En: IX Curso de actualización en ginecología y obstetricia. Universidad de Antioquia.Facultad de Medicina. 2001.
7. Tierney, McPhee, Papadakis. Diagnóstico clínico y tratamiento 2003. 38ª ed, México, Manual Moderno, 2003: 770-773
8. Estrada AA, Hernández PJA, Cisneros CM, García-Benites CQ. Experiencia de la Unidad de Cuidados Intensivos Obstétricos del Instituto Nacional de Perinatología. Perinatol Reprod Hum 2002;16:88-95
9. Kilpatrick SJ, Matthay MA. A five year review.Obstetric Patients Requiring Critical Care 1992;(101):1407-1412.
10. Mabie WC, Sibai BM. Treatment in an obstetric intensive care unit. Am J. Obstetric Gynecology 1990;162:1-4.
11 Purkerson M, Vekerdy L. A history of eclampsia, toxemia and kidney in pregnancy. Am J Nephrology 1999;19:313-319
12. Weinstein L. It has been a great ride: the history of HELLP Syndrome. Am J Obstetric Gynecology 2005;
13.Merviela P, Carbillon L, Challierb JC, Rabreaud M, Beaufilse M, Uzan S. Pathophysiology of preeclampsia: links with implantation disorders. Review. European J Obstetric Gynecology Reprod Biol. 2004;115:134–47
14. Sikkema JM, Bruinse HW, Visser GH, Franx A. [Pregnancy complications as a risk factor for metabolic and cardiovascular disease in later life] [Ned Tijdschr Geneeskd. 2006 Apr22;150(16):898-902.
15. Committee on Terminology of the American College of Obstetricians and Gynecologists and National High Blood Pressure Education Program.
16. Chesley LC, Annitto JE, Cosgrove RA. The familial factor in toxemia of pregnancy. Obstet Gynecol 1968; 32:303-11.
17. Mogren I, Hogberg U, Winkvist A, Stenlund H. Familial occurrence of preeclampsia. Epidemiology 1999;10: 518-22.
18. ChesleyLC. The genetics of preeclampsia. Hypertension Pregnancy 1993;12:7-10.
19. Treloar SA, Cooper DW, Brennecke SP, Grehan MM, Martin NG. An Australian twin study of the genetic basis of preeclampsia and eclampsia. Am J Obstetric Gynecol 2001;184:374-81.
20. Cooper DW, Liston WA. Genetic control of severe pre-eclampsia. J Med Genet 1979;16:409-16.
21. Chesley LC, Cooper DW. Genetics of hypertensionin pregnancy: possible single gene control of preeclampsia and eclampsia in the descendants of eclamptic women. Br J Obstet Gynaecol 1986; 93:898- 908.
22. Zybina TG, Zybina EV. Genome multiplication In the tertiary giant trophoblast cells in the course of their endovascular and interstitial invasion into the rat placenta decidua basalis. Early Pregnancy: Biology and Medicine.2000;4(2):1099-109.
23. Zygmunt M, Herr F, Munstedt K, Lang U, Liang OD. Angiogenesis and vasculogenesis in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2003;110 Suppl 1:S10-8.
24. Shibuya M. Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Struct Funct. 2001;66:25-35.
25. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosinekinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:649-58.
26. Walker JJ. Preeclampsia. Lancet 2000;356:1260-5.
27. Kilpatrick DC. Influence of human leukocyte antigen and tumour necrosis factor genes on the development of pre-eclampsia. Hum Reprod Update 1999;5:94-102.
28. Lachmeijer A, Dekker GA, Pals G,...